137 related articles for article (PubMed ID: 17621629)
1. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma.
Kanagawa N; Niwa M; Hatanaka Y; Tani Y; Nakagawa S; Fujita T; Yamamoto A; Okada N
Int J Cancer; 2007 Nov; 121(9):2013-2022. PubMed ID: 17621629
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector.
Okada N; Sasaki A; Niwa M; Okada Y; Hatanaka Y; Tani Y; Mizuguchi H; Nakagawa S; Fujita T; Yamamoto A
Cancer Gene Ther; 2006 Apr; 13(4):393-405. PubMed ID: 16224496
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral IFN-α gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression.
Hirata A; Hashimoto H; Shibasaki C; Narumi K; Aoki K
Cancer Gene Ther; 2019 Sep; 26(9-10):334-343. PubMed ID: 30420718
[TBL] [Abstract][Full Text] [Related]
4. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
Kanagawa N; Gao JQ; Motomura Y; Yanagawa T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
Biochem Biophys Res Commun; 2008 Aug; 372(4):821-5. PubMed ID: 18519033
[TBL] [Abstract][Full Text] [Related]
5. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J
Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366
[TBL] [Abstract][Full Text] [Related]
6. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy.
Okada N; Gao JQ; Sasaki A; Niwa M; Okada Y; Nakayama T; Yoshie O; Mizuguchi H; Hayakawa T; Fujita T; Yamamoto A; Tsutsumi Y; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2004 Apr; 317(1):68-76. PubMed ID: 15047149
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral expression of macrophage-derived chemokine induces CD4+ T cell-independent antitumor immunity in mice.
Lee JM; Merritt RE; Mahtabifard A; Yamada R; Kikuchi T; Crystal RG; Korst RJ
J Immunother; 2003; 26(2):117-29. PubMed ID: 12616103
[TBL] [Abstract][Full Text] [Related]
10. A novel co-culture assay to assess anti-tumor CD8
Olivo Pimentel V; Yaromina A; Marcus D; Dubois LJ; Lambin P
J Immunol Methods; 2020 Dec; 487():112899. PubMed ID: 33068606
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of NK4, an angiogenesis inhibitor, induces CT26 tumor regression via tumor-specific T lymphocyte activation.
Kubota T; Taiyoh H; Matsumura A; Murayama Y; Ichikawa D; Okamoto K; Fujiwara H; Ikoma H; Nakanishi M; Kikuchi S; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Suzuki Y; Matsumoto K; Nakamura T; Otsuji E
Int J Cancer; 2009 Dec; 125(12):2879-86. PubMed ID: 19588506
[TBL] [Abstract][Full Text] [Related]
12. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
[TBL] [Abstract][Full Text] [Related]
13. Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets.
Kang S; Xie J; Ma S; Liao W; Zhang J; Luo R
Immunobiology; 2010; 215(2):153-62. PubMed ID: 19450895
[TBL] [Abstract][Full Text] [Related]
14. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
[TBL] [Abstract][Full Text] [Related]
15. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.
Furumoto K; Soares L; Engleman EG; Merad M
J Clin Invest; 2004 Mar; 113(5):774-83. PubMed ID: 14991076
[TBL] [Abstract][Full Text] [Related]
16. Gene electrotransfer of proinflammatory chemokines CCL5 and CCL17 as a novel approach of modifying cytokine expression profile in the tumor microenvironment.
Bozic T; Sersa G; Kranjc Brezar S; Cemazar M; Markelc B
Bioelectrochemistry; 2021 Aug; 140():107795. PubMed ID: 33789177
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector.
Gao JQ; Sugita T; Kanagawa N; Iida K; Okada N; Mizuguchi H; Nakayama T; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
Biol Pharm Bull; 2005 Jun; 28(6):1066-70. PubMed ID: 15930746
[TBL] [Abstract][Full Text] [Related]
19. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].
Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.
Fushimi T; O'Connor TP; Crystal RG
Cancer Res; 2006 Apr; 66(7):3513-22. PubMed ID: 16585175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
